Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer
4.9 (454) · $ 26.00 · In stock
Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.
Mechanisms of estrogen receptor (ER) actions and endocrine resistance
Foods To Eat And Avoid For ER-/PR+ Patients And Survivors
Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors - ScienceDirect
The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB)
Optimizing Treatment Options for HER2+/ ER+ Breast Cancer using Models of Endocrine Resistance
Cancers, Free Full-Text
Frontiers Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
PDF] The role of steroid hormones in breast cancer stem cells.
/wp-content
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
Estrogen/Progesterone Receptors (ER/PR Receptors)
Current Oncology, Free Full-Text
